Les Sulewski
Stock Analyst at Truist Securities
(0.76)
# 4,011
Out of 5,182 analysts
19
Total ratings
35.29%
Success rate
-13.98%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $18 | $7.27 | +147.59% | 1 | Mar 5, 2026 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $15 → $17 | $13.91 | +22.21% | 4 | Mar 2, 2026 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Buy | $38 → $42 | $32.40 | +29.63% | 3 | Feb 18, 2026 | |
| BHC Bausch Health Companies | Maintains: Hold | $7 → $8 | $5.90 | +35.59% | 1 | Jan 7, 2026 | |
| PCRX Pacira BioSciences | Maintains: Buy | $30 → $28 | $24.72 | +13.27% | 7 | Nov 7, 2025 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $45 → $48 | $34.41 | +39.49% | 3 | Nov 7, 2025 |
Vanda Pharmaceuticals
Mar 5, 2026
Initiates: Buy
Price Target: $18
Current: $7.27
Upside: +147.59%
Amneal Pharmaceuticals
Mar 2, 2026
Maintains: Buy
Price Target: $15 → $17
Current: $13.91
Upside: +22.21%
Teva Pharmaceutical Industries
Feb 18, 2026
Maintains: Buy
Price Target: $38 → $42
Current: $32.40
Upside: +29.63%
Bausch Health Companies
Jan 7, 2026
Maintains: Hold
Price Target: $7 → $8
Current: $5.90
Upside: +35.59%
Pacira BioSciences
Nov 7, 2025
Maintains: Buy
Price Target: $30 → $28
Current: $24.72
Upside: +13.27%
Collegium Pharmaceutical
Nov 7, 2025
Maintains: Buy
Price Target: $45 → $48
Current: $34.41
Upside: +39.49%